case_images: PMC4530232_01
case_images: (a) Chest radiograph showing extensive multifocal consolidation and cavitation predominantly in the right upper lobe. (b) Computed tomography (CT) image scan obtained 5 weeks later shows the persistence of some caverns, nodules, and linear opacities but a significant improvement in areas of consolidation. (c) An oronasal mask was used to minimize air leakage and improve tolerance for noninvasive ventilation. Health personnel should not overlook the risk of tuberculosis transmission associated with short distances exposures.
case_images: CRIPU2015-283867.001.jpg
case_images: PMC4530232_01_CRIPU2015-283867.001.jpg
case_images: fig1
case_images: A chest X-ray showed diffuse alveolar and nodular opacities, as well an extensive right upper lobe cavitary disease (Figure 1).
case_images: Changes in SatO2 and PaCO2 and respiratory rate (RR) in relation to the application of noninvasive pressure support ventilation (NIPSV) and 3 doses of etanercept 25 mg administered subcutaneously (black arrowheads).
case_images: CRIPU2015-283867.002.jpg
case_images: PMC4530232_01_CRIPU2015-283867.002.jpg
case_images: fig2
case_images: The following day the patient showed a general improvement and an improved respiratory condition (Figure 2). However, 4 days after the second dose of etanercept, the patient experienced exacerbation of respiratory symptoms, malaise, and fever of 100.5 F (Figure 2).